NSTK Nastech Pharmaceutical Company (MM)

Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) announced today that it will present at the Invest Northwest CEO & Investor Forum on Tuesday, March 18, 2008, at 4:30 p.m. Pacific Time at the Bell Harbor International Conference Center in Seattle, Washington. To access the live audio webcast for this conference, please log on to Nastech�s Web site at http://www.nastech.com approximately 15 minutes prior to the presentation in order to register and download any necessary software. A replay of the audio presentation will be available following the event. About Nastech Nastech is a clinical stage biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products based on its proprietary molecular biology-based drug delivery technologies and, through its wholly-owned subsidiary, MDRNA, Inc., based on its proprietary ribonucleic acid interference (RNAi) technology. Nastech and its collaboration partners are developing products for multiple therapeutic areas including osteoporosis, obesity, diabetes, autism, respiratory diseases and inflammatory conditions. Additional information about Nastech is available at http://www.nastech.com.